Integral Ad Science Holding Full Year 2024 Earnings: EPS Misses Expectations
Integral Ad Science Reports Strong Growth and Expansion
Truist Securities Adjusts Integral Ad Science Holding Price Target to $17 From $16, Maintains Buy Rating
Earnings Call Summary | Integral Ad Science(IAS.US) Q4 2024 Earnings Conference
Integral Ad Science Stock Soars 14.8% on Strong Q4 Revenue, Upbeat Guidance
Integral Ad Science Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Sales Results and Issued Q1 Sales Guidance Above Estimates.
INTEGRAL AD SCIENCE HOLDING Earnings Results: $IAS Reports Quarterly Earnings
Earnings Flash (IAS) Integral Ad Science Holding Posts Q4 Revenue $153M, Vs. FactSet Est of $148.8M
Express News | Integral Ad Science Expects To Deliver Profitable, Double-digit Revenue Growth In 2025
Integral Ad Science 4Q Rev $153M >IAS
Integral Ad Science Q4 2024 GAAP EPS $0.09 Misses $0.10 Estimate, Sales $153.04M Beat $148.82M Estimate
Challenger Limited Becomes Substantial Holder in Integral Diagnostics
Challenger Limited Acquires Substantial Stake in Integral Diagnostics
Top Wall Street Forecasters Revamp Integral Ad Science Price Expectations Ahead Of Q4 Earnings
Are Poor Financial Prospects Dragging Down Integral Diagnostics Limited (ASX:IDX Stock?
Integral Diagnostics First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags
Integral Ad Science (IAS) Q4 Earnings: What To Expect
Canaccord Genuity Upgrades Integral Diagnostics to Buy From Hold; Price Target Is AU$2.90
Bell Potter Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Ltd. (IDX) Gets a Hold From Citi